Literature DB >> 31021399

Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series.

J C Armario-Hita1, J Pereyra-Rodriguez2, J F Silvestre3, R Ruiz-Villaverde4, A Valero, R Izu-Belloso, I Jáuregui-Presa, L Curto-Barredo, I Figueras-Nart, P Herranz-Pinto, L Herraez-Herrera, F J Ortiz-de-Frutos, L Martinez-Pilar, J Sastre, E Serra-Baldrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31021399     DOI： 10.1111/bjd.18041

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.

Authors:  Lawrence F Eichenfield; April Armstrong; Emma Guttman-Yassky; Peter A Lio; Chi-Chang Chen; Dionne M Hines; Catherine B McGuiness; Sohini Ganguli; Dimittri Delevry; Debra Sierka; Usha G Mallya
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-11

2.  Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey.

Authors:  Joaquín Sastre; Esther Serra Baldrich; José Carlos Armario Hita; L Herráez; Ignacio Jáuregui; Ana Martín-Santiago; Javier Ortiz de Frutos; Juan Francisco Silvestre; Antonio Valero
Journal:  Dermatol Res Pract       Date:  2020-04-07

Review 3.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

4.  104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain.

Authors:  Jose Juan Pereyra-Rodriguez; Javier Dominguez-Cruz; Jose Carlos Armario-Hita; Ricardo Ruiz-Villaverde
Journal:  An Bras Dermatol       Date:  2021-09-27       Impact factor: 1.896

Review 5.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

6.  Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience.

Authors:  Silvia Ferrucci; Giovanni Casazza; Luisa Angileri; Simona Tavecchio; Francesca Germiniasi; Emilio Berti; Angelo Valerio Marzano; Giovanni Genovese
Journal:  J Clin Med       Date:  2020-03-13       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.